- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05216302
Prehabilitation for Breast Cancer Surgery
Prehabilitation Program Based on Health Education and Nordic Walking to Reduce Musculoskeletal Impairments in Women Undergoing Breast Cancer Surgery
Prehabilitation for women diagnosed with breast cancer is commonly not part of the clinical pathways as little time (usually a few days) is left between diagnosis and surgery. However, a great proportion of these patients will undergo neoadjuvant chemotherapy which provides a window opportunity to improve patients' physical status to withstand surgery and minimize post-operative musculoskeletal complications associated with surgery.
To this end, the aim of this study is to assess the efficacy of a prehabilitation program consisting of health education and a supervised nordic walking-based intervention in women diagnosed with breast cancer currently undergoing neoadjuvant chemotherapy to decrease post-operative musculoskeletal impairments and improve functionality of the affected arm.
The study is an open-label, single-blind randomised controlled trial conducted at one tertiary hospital. Women diagnosed with breast cancer scheduled for surgery and currently undergoing chemotherapy will be randomised to either usual care (UC) or prehabilitation (PREHAB). Patients will be assessed for eligibility during the fourth out of six course of chemotherapy. Those randomised to the PREHAB group will participate in a supervised group-based nordic walking intervention twice weekly during 8 weeks (approximately 16 sessions). In addition, participants will receive written information regarding the benefits of exercise during cancer treatment and surveillance. Patients will be assessed prior to surgery as well as at 1, 3 and 6 months postoperatively.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anabel Casanovas Álvarez, MSc
- Phone Number: 10340 +34931696573
- Email: acasanovasa@tecnocampus.cat
Study Contact Backup
- Name: Raquel Sebio, PhD
- Email: rsebio@tecnocampus.cat
Study Locations
-
-
-
Barcelona, Spain, 08041
- Recruiting
- Hospital Santa Creu i Sant Pau
-
Contact:
- Jaume Masià, PhD
- Phone Number: +34935565775
- Email: JMasia@santpau.cat
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of breast cancer scheduled for surgery with or without lymphadenectomy
- Candidates to receive neoadjuvant chemotherapy
- Not currently undergoing any other physical therapy therapies or treatments
Exclusion Criteria:
- Cognitive impairment or inability to read Catalan or Spanish
- Prior diagnosis of shoulder impairment or injury
- Major musculoskeletal, neurological or cardiorespiratory limitations to prevent participation in the exercise program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
Patients allocated to this arm will continue with their schedule chemotherapy with no additional intervention
|
|
Experimental: Prehabilitation
Patients allocated to this arm will participate in a weekly group-based exercise intervention (nordic walking) and receive health education through a booklet, videos of the exercises and face-to-face sessions prior to each nordic walking session.
Chemotherapy will continue as scheduled.
|
An exercise intervention based on nordic walking and health education of one hour and 15 minutes per session.
Each session includes 10 min of health education followed by 15 minutes of warm-up exercises, 30 minutes of nordic walking and finally 15 min to cool-down.
The intervention is meant to last during two months (last round of chemotherapy and one month pre-surgery), twice weekly for approximately a total of 16 sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Pre-Surgery (one week)
|
Functionality of the affected upper arm using the DASH questionnaire.
The questionnaire compromises 11 items.
Scoring ranges from 0 (no disability) to 100 (more severe disability)
|
Pre-Surgery (one week)
|
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: One month post-surgery
|
Functionality of the affected upper arm using the DASH questionnaire.
The questionnaire compromises 11 items.
Scoring ranges from 0 (no disability) to 100 (more severe disability)
|
One month post-surgery
|
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Three months post-surgery
|
Functionality of the affected upper arm using the DASH questionnaire.
The questionnaire compromises 11 items.
Scoring ranges from 0 (no disability) to 100 (more severe disability)
|
Three months post-surgery
|
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Six months post-surgery
|
Functionality of the affected upper arm using the DASH questionnaire.
The questionnaire compromises 11 items.
Scoring ranges from 0 (no disability) to 100 (more severe disability)
|
Six months post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper arm volume
Time Frame: Pre-Surgery (one week)
|
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
|
Pre-Surgery (one week)
|
Upper arm volume
Time Frame: One month post-surgery
|
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
|
One month post-surgery
|
Upper arm volume
Time Frame: Three months post-surgery
|
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
|
Three months post-surgery
|
Upper arm volume
Time Frame: Six months post-surgery
|
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
|
Six months post-surgery
|
Range of Movement (ROM)
Time Frame: Pre-Surgery (one week)
|
Range of movement of the affected arm in three axes using a goniometer
|
Pre-Surgery (one week)
|
Range of Movement (ROM)
Time Frame: One month post-surgery
|
Range of movement of the affected arm in three axes using a goniometer
|
One month post-surgery
|
Range of Movement (ROM)
Time Frame: Three months post-surgery
|
Range of movement of the affected arm in three axes using a goniometer
|
Three months post-surgery
|
Range of Movement (ROM)
Time Frame: Six months post-surgery
|
Range of movement of the affected arm in three axes using a goniometer
|
Six months post-surgery
|
Pain severity
Time Frame: Pre-Surgery (one week)
|
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
|
Pre-Surgery (one week)
|
Pain severity
Time Frame: One month post-surgery
|
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
|
One month post-surgery
|
Pain severity
Time Frame: Three months post-surgery
|
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
|
Three months post-surgery
|
Pain severity
Time Frame: Six months post-surgery
|
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
|
Six months post-surgery
|
Health-Related Quality of Life
Time Frame: Pre-Surgery (one week)
|
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30).
Scores range from 0 to 100 with higher values associated with better overall quality of life
|
Pre-Surgery (one week)
|
Health-Related Quality of Life
Time Frame: One month post-surgery
|
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30).
Scores range from 0 to 100 with higher values associated with better overall quality of life
|
One month post-surgery
|
Health-Related Quality of Life
Time Frame: Three months post-surgery
|
HHealth-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30).
Scores range from 0 to 100 with higher values associated with better overall quality of life
|
Three months post-surgery
|
Health-Related Quality of Life
Time Frame: Six months post-surgery
|
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30).
Scores range from 0 to 100 with higher values associated with better overall quality of life
|
Six months post-surgery
|
Handgrip Strength
Time Frame: Pre-Surgery (one week)
|
Handgrip strength will be determined using an hydraulic dynamometer (Jamar).
Both hands will be assessed and the better result out of three attempts will be used.
|
Pre-Surgery (one week)
|
Handgrip Strength
Time Frame: One month post-surgery
|
Handgrip strength will be determined using an hydraulic dynamometer (Jamar).
Both hands will be assessed and the better result out of three attempts will be used.
|
One month post-surgery
|
Handgrip Strength
Time Frame: Three months post-surgery
|
Handgrip strength will be determined using an hydraulic dynamometer (Jamar).
Both hands will be assessed and the better result out of three attempts will be used.
|
Three months post-surgery
|
Handgrip Strength
Time Frame: Six months post-surgery
|
Handgrip strength will be determined using an hydraulic dynamometer (Jamar).
Both hands will be assessed and the better result out of three attempts will be used.
|
Six months post-surgery
|
Functional capacity
Time Frame: Pre-surgery (one week)
|
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
|
Pre-surgery (one week)
|
Functional capacity
Time Frame: One month post-surgery
|
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
|
One month post-surgery
|
Functional capacity
Time Frame: Three months post-surgery
|
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
|
Three months post-surgery
|
Functional capacity
Time Frame: Six months post-surgery
|
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
|
Six months post-surgery
|
Adherence
Time Frame: Pre-Surgery (one week)
|
Adherence to the scheduled sessions will be registered in the Prehab group and will be reported as percentage of attended vs. scheduled.
|
Pre-Surgery (one week)
|
Physical Activity
Time Frame: Pre-surgery (one week)
|
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ).
Estimated METS per week will be calculated based on the available formulas.
|
Pre-surgery (one week)
|
Physical Activity
Time Frame: One month post-surgery
|
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ).
Estimated METS per week will be calculated based on the available formulas.
|
One month post-surgery
|
Physical Activity
Time Frame: Three months post-surgery
|
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ).
Estimated METS per week will be calculated based on the available formulas.
|
Three months post-surgery
|
Physical Activity
Time Frame: Six months post-surgery
|
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ).
Estimated METS per week will be calculated based on the available formulas.
|
Six months post-surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Raquel Sebio, PhD, School of Health Sciences TecnoCampus. University Pompeu Fabra
Publications and helpful links
General Publications
- McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006 Jul 4;175(1):34-41. doi: 10.1503/cmaj.051073.
- Silver JK, Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil. 2013 Aug;92(8):715-27. doi: 10.1097/PHM.0b013e31829b4afe.
- Santa Mina D, Brahmbhatt P, Lopez C, Baima J, Gillis C, Trachtenberg L, Silver JK. The Case for Prehabilitation Prior to Breast Cancer Treatment. PM R. 2017 Sep;9(9S2):S305-S316. doi: 10.1016/j.pmrj.2017.08.402.
- Yang A, Sokolof J, Gulati A. The effect of preoperative exercise on upper extremity recovery following breast cancer surgery: a systematic review. Int J Rehabil Res. 2018 Sep;41(3):189-196. doi: 10.1097/MRR.0000000000000288.
- ILokapavani Y, Krishna SR, Madhavi K. nfluence of Pre - Operative Physical Therapy Education and Exercise on Post-operative Shoulder Range of Motion and Functional Activites in Subjects with Modified Radical Mastectomy. Int J Physiother 2014. DOI: 10.15621/ijphy/2014/v1i4/54556
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-PRO-2021-10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
Clinical Trials on Group-based Nordic Walking Exercise Program
-
Bispebjerg HospitalCompleted
-
Pusan National UniversityMarymount University; Dong-Eui UniversityCompletedPeripheral Arterial Disease | Peripheral Artery Disease | Vascular Function | Exercise Tolerance
-
University of SaskatchewanSaskatchewan Health Research Foundation; Royal University Hospital Foundation; Saskatchewan Centre for Patient-Oriented ResearchCompletedOsteoporosis | Vertebral Fracture | HyperkyphosisCanada
-
Grand Valley State UniversityCompletedParkinson DiseaseUnited States
-
Universitat Pompeu FabraCol·legi de Fisioterapeutes de Catalunya; Ajuntament de MataróNot yet recruiting
-
Hospital of South West JutlandUniversity of Southern DenmarkCompletedType 2 Diabetes | ExerciseDenmark
-
Dublin City UniversityCompletedHamstring InjuryIreland
-
Cairo UniversityNot yet recruiting
-
US Department of Veterans AffairsCompletedPain | Obesity | Osteoarthritis | Chronic DiseasesUnited States
-
Chulalongkorn UniversityRecruitingElderly With Type 2 DiabetesThailand